Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

636 ARTÍCULOS , VIENDO DEL 1 AL 15

Eye Movement Disorders Following Allogeneic Bone Marrow Transplantation on FK506 (Tacrolimus) and Ganciclovir

Karagun BS, Akbas T, Arpaci T, Antmen B.

J Pediatr Hematol Oncol. 2018 Jan;40(1):71-73. doi: 10.1097/MPH.0000000000000870.

Disabling Central Paroxysmal Positioning Upbeat Nystagmus and Vertigo Associated With the Presence of Anti-Glutamic Acid Decarboxylase Antibodies

Martins AI, Carvalho JN, Amorim AM, Geraldo A, Eggenberger E, Lemos J.

J Neuroophthalmol. 2018 Mar;38(1):32-35. doi: 10.1097/WNO.0000000000000547.

Neurosurgical Patients as Human Research Subjects: Ethical Considerations in Intracranial Electrophysiology Research

Chiong W, Leonard MK, Chang EF.

Neurosurgery. 2018 Jul 1;83(1):29-37. doi: 10.1093/neuros/nyx361.

[New aspects of symptomatic MS treatment: Part 4-sexual dysfunction and eye movement disorders]

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG.

Nervenarzt. 2018 Feb;89(2):193-197. doi: 10.1007/s00115-017-0441-9.

Neuroanatomy of conversion disorder: towards a network approach

Conejero I, Thouvenot E, Abbar M, Mouchabac S, Courtet P, Olié E.

Rev Neurosci. 2018 Jun 27;29(4):355-368. doi: 10.1515/revneuro-2017-0041.

Botulinum toxin for motor and phonic tics in Tourette's syndrome

Pandey S, Srivanitchapoom P, Kirubakaran R, Berman BD.

Cochrane Database Syst Rev. 2018 Jan 5;1(1):CD012285. doi: 10.1002/14651858.CD012285.pub2.

A 15-Year-Old Boy with Mysterious Variability in Apnea-Hypopnea Index

May AM, Gandotra K, Auckley DH.

Chest. 2018 Jan;153(1):e9-e12. doi: 10.1016/j.chest.2016.09.007.

Listeria monocytogenes sepsis in the nursing home community: a case report and short review of the literature

Buyck G, Devriendt V, Van den Abeele AM, Bachmann C.

Acta Clin Belg. 2018 Dec;73(6):418-422. doi: 10.1080/17843286.2017.1421846. Epub 2018 Jan 9.

2018 message from the editor in chief-Movement Disorders journal at cruise speed

Obeso JA.

Mov Disord. 2018 Jan;33(1):1-2. doi: 10.1002/mds.27289.

Valbenazine as the first and only approved treatment for adults with tardive dyskinesia

Sarva H, Henchcliffe C.

Expert Rev Clin Pharmacol. 2018 Mar;11(3):209-217. doi: 10.1080/17512433.2018.1429264. Epub 2018 Jan 23.

Vitamin E for antipsychotic-induced tardive dyskinesia

Soares-Weiser K, Maayan N, Bergman H.

Cochrane Database Syst Rev. 2018 Jan 17;1(1):CD000209. doi: 10.1002/14651858.CD000209.pub3.

Anticholinergic medication for antipsychotic-induced tardive dyskinesia

Bergman H, Soares-Weiser K.

Cochrane Database Syst Rev. 2018 Jan 17;1(1):CD000204. doi: 10.1002/14651858.CD000204.pub2.

Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia

El-Sayeh HG, Rathbone J, Soares-Weiser K, Bergman H.

Cochrane Database Syst Rev. 2018 Jan 18;1(1):CD000458. doi: 10.1002/14651858.CD000458.pub3.

Lower body blood flow restriction training may induce remote muscle strength adaptations in an active unrestricted arm

May AK, Russell AP, Warmington SA.

Eur J Appl Physiol. 2018 Mar;118(3):617-627. doi: 10.1007/s00421-018-3806-2. Epub 2018 Jan 19.

Benzodiazepines for antipsychotic-induced tardive dyskinesia

Bergman H, Bhoopathi PS, Soares-Weiser K.

Cochrane Database Syst Rev. 2018 Jan 20;1(1):CD000205. doi: 10.1002/14651858.CD000205.pub3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias